The $2 Trillion Valuation Debate Skips What Anthropic Knows
Pharmacore secures funding to improve medication regimen reviews in long-term care
New ESW Guide Explains Copilot Studio Agent Pricing and the Controls to Set First
EMH Group modernises resident WiFi across its estate with Purple
TestMu AI Launches New Experience in KaneAI, Turning Recorded Tests into Objectives That Repair Themselves
Data presented at AACR Annual Meeting support IMM-1-104’s potential to address a broad population of…
Data presented at AACR Annual Meeting support IMM-1-104’s potential to address a broad population of…
Preclinical data suggests that sudocetaxel zendusortide can induce immune cell infiltration in “cold” tumors and…
Preclinical data suggests that sudocetaxel zendusortide can induce immune cell infiltration in “cold” tumors and…
Data demonstrated D-4559 switches tumor associated macrophages from an M2 to M1 pro-inflammatory phenotype leading…
Data demonstrated D-4559 switches tumor associated macrophages from an M2 to M1 pro-inflammatory phenotype leading…
– 100% accuracy predicting clinical responders with Notable’s PPMP with enhanced machine learning – – Fourth clinical…
– 100% accuracy predicting clinical responders with Notable’s PPMP with enhanced machine learning – – Fourth clinical…
APN401 induced prolonged stable disease in two heavily pre-treated patients, using invIOs’s proprietary rapid cell-processing…
APN401 induced prolonged stable disease in two heavily pre-treated patients, using invIOs’s proprietary rapid cell-processing…
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a fully integrated biopharmaceutical…
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a fully integrated biopharmaceutical…
Qualigen Therapeutics, Inc. Abstract #4981 Qualigen Therapeutics, Inc. Abstract #6240 CARLSBAD, Calif., April 18, 2023…
Qualigen Therapeutics, Inc. Abstract #4981 Qualigen Therapeutics, Inc. Abstract #6240 CARLSBAD, Calif., April 18, 2023…
The iLSTA Trial is the first study combining LSTA1 with standard-of-care chemotherapy and immunotherapy WARPNINE…
The iLSTA Trial is the first study combining LSTA1 with standard-of-care chemotherapy and immunotherapy WARPNINE…
JUPITER, Fla., April 18, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
Underserved Maryland residents and businesses across the state to get access to Fios internet NEW…